Stay updated with breaking news from Including Those Present. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In Vitro Studies Show Ensovibep (MP0420) Maintains Full Potency Against the Known Mutations of SARS-CoV-2, Including Those Present in Variants First Identified in Brazil, California, India, and New
Share: In Vitro Studies Show Ensovibep (MP0420) Maintains Full Potency Against the Known Mutations of SARS-CoV-2, Including Those Present in Variants First Identified in Brazil, California, India, and New York, in Addition to the Previously Reported Varia Ongoing Phase 2 Pilot Study of Ensovibep in Ambulatory Patients Now Expanding Into Second Cohort Two Global Phase 2 and 3 Clinical Studies of Ensovibep on Track for Initiation This Month ZURICH-SCHLIEREN, SWITZERLAND / ACCESSWIRE / May 6, 2021 / Molecular Partners AG (SIX:MOLN), a clinical-stage biotech company developing a new class of cust...